Ticker Details
Lantheus Holdings, Inc. Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging.
IPO Date:	June 25, 2015
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$6.53B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.93 | 2.48%
Avg Daily Range (30 D):	$1.17 | 1.13%
Avg Daily Range (90 D):	$1.47 | 1.51%

Institutional Daily Volume
Avg Daily Volume:	.59M
Avg Daily Volume (30 D):	1.39M
Avg Daily Volume (90 D):	.98M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	77
Avg Trade Size (Sh.) (90 D):	61

Institutional Trades
Total Institutional Trades:	6,458
Avg Institutional Trade:	$3.72M
Avg Institutional Trade (30 D):	$6.82M
Avg Institutional Trade (90 D):	$6.58M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$6.45M
Avg Closing Trade (30 D):	$18.64M
Avg Closing Trade (90 D):	$16.48M
Avg Closing Volume:	109.74K

News

Aug 4, 2026 @ 6:11 PM Halper Sadeh LLC is Investigating Whether MKTX, SM... Source: Halper Sadeh Llc

Aug 3, 2026 @ 11:38 AM Curium Announces Definitive Agreement to Merge wit... Source: Na

Aug 3, 2026 @ 11:31 AM Curium Announces Definitive Agreement to Merge wit... Source: Na

Jun 10, 2026 @ 5:00 PM Metastatic Prostate Cancer Market Set for Robust G... Source: Delveinsight

Apr 24, 2026 @ 1:57 PM Radiopharmaceuticals Market Size to Exceed USD 15.... Source: Precedence Research

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$4.22	$1.15	$1.83
Diluted EPS	$4.13	$1.11	$1.8
Revenue	$1.56B	$388.18M	$377.33M
Gross Profit	$936.02M	$241.86M	$230.92M
Net Income / Loss	$275.31M	$75.03M	$118.42M
Operating Income / Loss	$302.34M	$100.22M	$81.33M
Cost of Revenue	$620.3M	$146.33M	$146.41M
Net Cash Flow	$-102.25M	$94.72M	$139.47M
PE Ratio